Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

PET-based treatment planning in radiotherapy: a new standard?

Grégoire V, Haustermans K, Geets X, Roels S, Lonneux M.

J Nucl Med. 2007 Jan;48 Suppl 1:68S-77S. Review.

2.
3.

Positron emission tomography for radiation treatment planning.

Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, Zimmermann FB, Schwaiger M, Molls M.

Strahlenther Onkol. 2005 Aug;181(8):483-99. Review.

PMID:
16044216
4.

Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C, Kirsch CM.

J Nucl Med. 2005 Aug;46(8):1342-8.

6.

Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.

Moureau-Zabotto L, Touboul E, Lerouge D, Deniaud-Alexandre E, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Kerrou K, Montravers F, Keraudy K, Tiret E, Gendre JP, Grange JD, Houry S, Talbot JN.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):340-5.

PMID:
16168829
7.

Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.

Grills IS, Yan D, Black QC, Wong CY, Martinez AA, Kestin LL.

Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):709-19. Epub 2006 Dec 29. Review.

PMID:
17197120
8.

Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.

Hong R, Halama J, Bova D, Sethi A, Emami B.

Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):720-6.

PMID:
17293230
9.
10.

Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.

Guido A, Fuccio L, Rombi B, Castellucci P, Cecconi A, Bunkheila F, Fuccio C, Spezi E, Angelini AL, Barbieri E.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):759-63. doi: 10.1016/j.ijrobp.2008.04.059. Epub 2008 Oct 1.

PMID:
18834671
11.

Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S.

J Nucl Med. 2009 Jul;50(7):1020-7. doi: 10.2967/jnumed.109.062638. Epub 2009 Jun 12.

12.

18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?

Biehl KJ, Kong FM, Dehdashti F, Jin JY, Mutic S, El Naqa I, Siegel BA, Bradley JD.

J Nucl Med. 2006 Nov;47(11):1808-12.

13.

Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.

Schinagl DA, Vogel WV, Hoffmann AL, van Dalen JA, Oyen WJ, Kaanders JH.

Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1282-9.

PMID:
17967318
14.

Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).

Greco C, Rosenzweig K, Cascini GL, Tamburrini O.

Lung Cancer. 2007 Aug;57(2):125-34. Epub 2007 May 2. Review.

PMID:
17478008
15.

[The impact of integrating images of positron emission tomography with computed tomography simulation on radiation therapy planning].

Touboul E, Deniaud-Alexandre E, Moureau-Zabotto L, Lerouge D.

Cancer Radiother. 2004 Nov;8 Suppl 1:S29-35. Review. French.

PMID:
15679244
16.

A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.

Leong T, Everitt C, Yuen K, Condron S, Hui A, Ngan SY, Pitman A, Lau EW, MacManus M, Binns D, Ackerly T, Hicks RJ.

Radiother Oncol. 2006 Mar;78(3):254-61. Epub 2006 Mar 20.

PMID:
16545881
17.

Impact of integrated PET/CT on variability of target volume delineation in rectal cancer.

Patel DA, Chang ST, Goodman KA, Quon A, Thorndyke B, Gambhir SS, McMillan A, Loo BW Jr, Koong AC.

Technol Cancer Res Treat. 2007 Feb;6(1):31-6.

PMID:
17241098
18.

Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.

Zheng XK, Chen LH, Wang QS, Wu HB, Wang HM, Chen YQ, Yan WP, Li QS, Xu YK.

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1381-8. Epub 2007 Sep 14.

PMID:
17869450
19.

Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer.

Nestle U, Schaefer-Schuler A, Kremp S, Groeschel A, Hellwig D, Rübe C, Kirsch CM.

Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):453-62. Epub 2006 Oct 21.

PMID:
17058078
20.

Assessment of 18F PET signals for automatic target volume definition in radiotherapy treatment planning.

Davis JB, Reiner B, Huser M, Burger C, Székely G, Ciernik IF.

Radiother Oncol. 2006 Jul;80(1):43-50. Epub 2006 Jul 28.

PMID:
16876272
Items per page

Supplemental Content

Write to the Help Desk